Researchers also found that knocking down HDAC5 and HDAC6 via a gene-editing strategy dramatically blocked Ang II-induced hypertrophic responses in cardiac hypertrophy and fibrosis 23. Here, HDAC5 is linked to cardiac hypertrophy.